Comparison between the Pidrolax and simultaneous use laxa plus and Pidrolax in the pediatric constipation

Comparative evaluation Pidrolax powder and simultaneous use laxa plus syrup and Pidrolax powder in the pediatric functional constipation in patients 4 to 10 years old

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201029049185N1

Enrollment

108

Registered

2020-11-26

Start date

2019-11-22

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation. Other constipation

Interventions

Intervention 1: Intervention group: Patients in this group received Pidrolax plus Laxa plus medication regimen. Pidrolax 10 grams daily and 2.5 cc of Laxa plus. Intervention 2: Control group: Patients

Eligibility

Sex/Gender

All

Age

4 Years to 10 Years

Inclusion criteria

Inclusion criteria: Functional constipation confirmed by ROME III criteria

Exclusion criteria

Exclusion criteria: Hypothyroidism and history of bowel surgery

Design outcomes

Primary

Measure	Time frame
Constipation treatment. Timepoint: End of the second and fourth months after treatment. Method of measurement: Self-made questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohmad Javad Qasem zade

Islamic Azad University

qasemzade.m@gmail.com+98 25 3778 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026